Amos Meltzer

Mr. Meltzer with over 25 years of experience in international trade and in commercialising technologies, life sciences sector. He has presided over life science research and product development projects clinical trials and the commercialisation of life sciences assets through both licensing and the sale and marketing of a pharmaceutical product. Previously he served as General Counsel and IP director at two Nasdaq listed companies Compugen and Gilat, as a non executive director of a biotechnology company Evogene and as VP of Business Development and then CEO of an ASX listed biopharmaceutical company Immuron.